Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder.
作者信息
Leslie Laurel K, Alexander Mark E, Trikalinos Thomas A, Cohen Joshua T, Parsons Susan K, Newburger Jane W
机构信息
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Mass 02111, USA.
出版信息
Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):134-7. doi: 10.1161/CIRCOUTCOMES.108.825232.
Abstract
摘要
相似文献
1
Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder.重新审视皇帝的新衣：当前针对患有注意力缺陷多动障碍的青少年的心脏筛查建议中的模糊之处。
Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):134-7. doi: 10.1161/CIRCOUTCOMES.108.825232.
2
Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.注意缺陷多动障碍药物治疗的心血管安全性
Mt Sinai J Med. 2009 Apr;76(2):198-203. doi: 10.1002/msj.20096.
3
ECGs before stimulants in children.儿童使用兴奋剂之前的心电图。
Med Lett Drugs Ther. 2008 Jul 28;50(1291):60.
4
Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians.在兴奋剂治疗 ADHD 之前进行心脏筛查：对美国儿科医生的调查。
Pediatrics. 2012 Feb;129(2):222-30. doi: 10.1542/peds.2011-1574. Epub 2012 Jan 16.
5
Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.儿童和青少年使用兴奋剂药物前的心脏风险评估：加拿大儿科学会、加拿大心血管学会和加拿大儿童与青少年精神病学会联合立场声明
Can J Cardiol. 2009 Nov;25(11):625-30. doi: 10.1016/s0828-282x(09)70157-6.
6
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.用于注意力缺陷多动障碍的心血管监测与兴奋剂药物
Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573.
7
Stimulants for kids with ADHD--how to proceed safely.用于多动症儿童的兴奋剂——如何安全使用
J Fam Pract. 2014 Feb;63(2):E1-5.
8
Survey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulants.美国儿童及青少年精神科医生在开始让患者服用兴奋剂之前的心脏筛查实践调查。
J Child Adolesc Psychopharmacol. 2012 Oct;22(5):375-84. doi: 10.1089/cap.2011.0141.
9
Stimulants and sudden death: what is a physician to do?兴奋剂与猝死：医生该怎么做？
Pediatrics. 2006 Sep;118(3):1215-9. doi: 10.1542/peds.2006-0942.
10
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.患有心脏病的儿童和青少年在接受治疗注意力缺陷多动障碍药物治疗时的心血管监测[已修正]：美国心脏协会青年先天性心脏病委员会心血管疾病理事会和心血管护理理事会的科学声明。
Circulation. 2008 May 6;117(18):2407-23. doi: 10.1161/CIRCULATIONAHA.107.189473. Epub 2008 Apr 21.
引用本文的文献
1
An Evaluation of Whether Routine QTc Interval Screening Is Necessary Prior to Starting ADHD Medications: Experience from a Large Retrospective Study.在开始使用注意力缺陷多动障碍药物之前进行常规QTc间期筛查是否必要的评估：来自一项大型回顾性研究的经验。
Pediatr Rep. 2024 Dec 11;16(4):1161-1168. doi: 10.3390/pediatric16040098.
2
Sudden unexplained cardiac arrest in apparently healthy children: a single-center experience.表面健康儿童的不明原因心脏骤停：单中心经验
Pediatr Cardiol. 2013 Mar;34(3):639-45. doi: 10.1007/s00246-012-0516-0. Epub 2012 Oct 4.
3
How to predict the impact of methylphenidate on cardiovascular risk in children with attention deficit disorder: methylphenidate improves autonomic dysfunction in children with ADHD.如何预测哌甲酯对注意力缺陷障碍儿童心血管风险的影响：哌甲酯可改善多动症儿童的自主神经功能障碍。
ISRN Pharmacol. 2012;2012:170935. doi: 10.5402/2012/170935. Epub 2012 Mar 5.
4
Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians.在兴奋剂治疗 ADHD 之前进行心脏筛查：对美国儿科医生的调查。
Pediatrics. 2012 Feb;129(2):222-30. doi: 10.1542/peds.2011-1574. Epub 2012 Jan 16.
5
Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.青少年运动员参加比赛前筛查预防心源性猝死的成本效益。
Ann Intern Med. 2010 Mar 2;152(5):276-86. doi: 10.7326/0003-4819-152-5-201003020-00005.
本文引用的文献
1
Reframing evidence synthesis as rhetorical action in the policy making drama.在政策制定的过程中将证据综合重新构建为修辞行动。
Healthc Policy. 2006 Jan;1(2):34-42.
2
Recently trained general pediatricians: perspectives on residency training and scope of practice.近期培训的普通儿科医生：对住院医师培训及执业范围的看法
Pediatrics. 2009 Jan;123 Suppl 1:S38-43. doi: 10.1542/peds.2008-1578J.
3
Using decision analysis to better evaluate pediatric clinical guidelines.运用决策分析来更好地评估儿科临床指南。
Health Aff (Millwood). 2008 Sep-Oct;27(5):1467-75. doi: 10.1377/hlthaff.27.5.1467.
4
American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.美国儿科学会/美国心脏协会对关于患有心脏病且正在接受注意力缺陷多动障碍药物治疗的儿童和青少年的心血管评估与监测声明的澄清：2008年5月16日。
J Dev Behav Pediatr. 2008 Aug;29(4):335. doi: 10.1097/DBP.0b013e31318185dc14.
5
Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.用于注意力缺陷多动障碍的心血管监测与兴奋剂药物
Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573.
6
Group's advice on cardiac testing for children with ADHD draws criticism.该组织关于对多动症儿童进行心脏检查的建议引发了批评。
JAMA. 2008 Jun 18;299(23):2735. doi: 10.1001/jama.299.23.2735.
7
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.患有心脏病的儿童和青少年在接受治疗注意力缺陷多动障碍药物治疗时的心血管监测[已修正]：美国心脏协会青年先天性心脏病委员会心血管疾病理事会和心血管护理理事会的科学声明。
Circulation. 2008 May 6;117(18):2407-23. doi: 10.1161/CIRCULATIONAHA.107.189473. Epub 2008 Apr 21.
8
Pediatric workforce: a look at pediatric cardiology data from the American Board of Pediatrics.
J Pediatr. 2006 Mar;148(3):384-385. doi: 10.1016/j.jpeds.2006.01.053.
9
The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies.注意缺陷多动障碍的年龄依赖性衰退：随访研究的荟萃分析
Psychol Med. 2006 Feb;36(2):159-65. doi: 10.1017/S003329170500471X.
10
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.全国共病调查复制研究中12个月内DSM-IV疾病的患病率、严重程度及共病情况。
Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617.
Zotero 插件